Publications by authors named "Rajesh Venugopal"

Claim this Profile
U
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma.
Harpreet Singh, Michael Brave, Julia A Beaver, Joyce Cheng, Shenghui Tang, Rajesh Venugopal

Clin Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy.
Geoffrey Kim, Gwynn Ison, Amy E McKee, Hui Zhang, Shenghui Tang, Rajesh Venugopal

Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recalls of Foods and Cosmetics by the U.S. Food and Drug Administration.
Rajesh Venugopal, Linda Tollefson, Frederick N Hyman, Bab Timbo, Ronald E Joyce

J Food Prot· August 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis